Caveolin-1 at the Crossroads of Diabetes and Alzheimer’s Disease: New Mechanisms, Biomarkers, and Therapeutic Opportunities
Type 2 diabetes mellitus (T2D) is increasingly recognized as a major risk factor for Alzheimer’s disease (AD), supporting the concept that chronic metabolic dysfunction contributes to neurodegeneration. Recent advances have identified caveolin-1 (CAV-1), the principal structural protein of caveolae, as an important reg...